Moderna says its COVID-19 vaccine is 94.5% effective

U.S. firm Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.

COVID-19 vaccine innovation

A U.S. scientific team has successfully redesigned a key protein from the coronavirus, and the modification could enable much faster and more stable production of vaccines worldwide.

COVID-19 vaccine safe, generates immune response

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted antibody activity.

First human trial of COVID-19 vaccine finds it is safe

The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research.

Coronavirus vaccine: when will it be ready?

About 35 companies and academic institutions are racing to create Covid-19 vaccine. 

10 Positive Updates on the COVID-19 From Around the World

If it seems that your news feed has been flooded with nerve-wracking updates on the COVID-19 outbreaks, have no fear—there are also plenty of positive updates on the pandemic as well.

World's Fastest Supercomputer Joins The Battle Against COVID-19

U.S biophysicists have used the IBM-built supercomputer SUMMIT to sift through thousands of molecules and find potential compounds that could be used as a new drug against the coronavirus responsible for the current COVID-19 pandemic.